Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER plus /PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience

作者:Ciccarese Mariangela; Fabi Alessandra; Moscetti Luca; Cazzaniga Maria Elena; Petrucelli Luciana; Forcignano Rosachiara; Lupo Laura Isabella; De Matteis Elisabetta; Chiuri Vincenzo Emanuele; Cairo Giuseppe; Febbraro Antonio; Giordano Guido; Giampaglia Marianna; Bilancia Domenico; La Verde Nicla; Maiello Evaristo; Morritti Maria; Giotta Francesco; Lorusso Vito; Latorre Agnese; Scavelli Claudio; Romito Sante; Cusmai Antonio; Palmiotti Gennaro; Surico Giammarco
来源:Breast Cancer Research and Treatment, 2017, 163(3): 587-594.
DOI:10.1007/s10549-017-4213-9